[DOI] [PubMed] [Google Scholar] 34.Duzel A., Vlainic J., Antunovic M., Malekinusic D., Vrdoljak B., Samara M., Gojkovic S., Krezic I., Vidovic T., Bilic Z., et al
Recent findings indicate that GLP1-RAs may also offer therapeutic benefits in managing hidradenitis suppurativa (HS), a chronic inflammatory skin disorder closely associated with metabolic abnormalities, including obesity, diabetes, and dyslipidemia
The evaluation of patient preferences regarding oral versus injectable therapies could also be considered, as oral therapies can offer quality-of-life benefits through simplified administration (albeit with oral semaglutide requiring administration in a fasting state with 120 ml of water, followed by a post-dose fasting period of at least 30 min for optimum efficacy) and through shorter waiting times to initiation, with injectable antidiabetic therapies often associated with delays before patient training can be delivered through the NHS in the UK [19]
It is generally better to wait until your weight is stable
